StockWatch
·
Other Pharmaceuticals
BuybackJul 6, 2026, 09:37 AM

Cosmos Health Authorizes $5 Million Share Repurchase Program

AI Summary

Cosmos Health Inc. announced that its Board of Directors authorized a share repurchase program of up to $5 million of its common stock. The program is set to run for six months, concluding on December 31, 2026, and allows for repurchases through various methods, including open market transactions and Rule 10b5-1 plans. CEO Greg Siokas highlighted that the program underscores confidence in the company's growth trajectory and operating fundamentals, noting that the repurchase amount represents nearly half of the company's market capitalization.

Key Highlights

  • Cosmos Health Inc. Board authorized a share repurchase program for up to $5 million.
  • The program covers currently outstanding common stock over a 6-month period.
  • The repurchase program ends on December 31, 2026, unless extended.
  • Shares may be repurchased through open market, privately-negotiated, or block purchases.
  • The company may use Rule 10b5-1 trading plans to facilitate repurchases.
  • CEO Greg Siokas stated the program reflects confidence in operating fundamentals and growth prospects.
  • The $5 million program represents almost half of the company's market capitalization as of June 29, 2026.